(5E)-5-[4-(difluoromethoxy)benzylidene]-2-mercapto-1,3-thiazol-4(5H)-one, 90.0%, 5g

(5S,8R,9S,10S,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)tetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one, 97%, 100mg

5-(4-Bromo-phenyl)-4-methyl-4H-[1,2,4]triazole-3-thiol, 95.0%, 5g

Sample vials ROTILABO® with thread ND13, Brown glass, with labelling space, 100 Piece(s)

2-Boc-4'-(Bromomethyl)biphenyl, 95.0%, 10g

3-(1,2,3,4-Tetrahydroisoquinoline-2-yl)propionic acid hydrochloride, 95.0%, 1g

(3-(3,4-Dimethylphenyl)-1-phenyl-1H-pyrazol-4-yl)methanol, 98%, 100mg

1-Vinylimidazole>98.0%(GC)(T)500mL

6-Chloro-5-nitropicolinic acid, 95.0%, 25g

2-Bromo-6-chloroaniline, 95.0%, 250mg

2-Bromo-5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazine, 97%, 100mg

Copper silicide, 25g

1-tert-Butyl 2-methyl 1H-pyrrole-1,2(2H,5H)-dicarboxylate, 98%, 250mg